CEA and CYFRA 21-1 as prognostic biomarker and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitors
DallâOlio, Filippo G., Abbati, Francesca, Facchinetti, Francesco, Massucci, Maria, Melotti, Barbara, Squadrilli, Anna, Buti, Sebastiano, Formica, Francesca, Tiseo, Marcello, Ardizzoni, AndreaVolume:
12
Journal:
Therapeutic Advances in Medical Oncology
DOI:
10.1177/1758835920952994
Date:
January, 2020
File:
PDF, 403 KB
2020